Area of research
Immunology · Genetics
Research interest
Research interests include Immunology, Immune system, Biology, Medicine, Antigen, and Effector.
Single-cell RNA-Seq analysis reveals cell subsets and gene signatures associated with rheumatoid arthritis disease activity
A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers
Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis
Serum tryptophan metabolites are associated with erosive hand osteoarthritis and pain: results from the DIGICOD cohort
Use of machine learning in osteoarthritis research: a systematic literature review
Polyclonal expansion of TCR Vβ 21.3 <sup>+</sup> CD4 <sup>+</sup> and CD8 <sup>+</sup> T cells is a hallmark of multisystem inflammatory syndrome in children
Fever during pregnancy as a risk factor for neurodevelopmental disorders: results from a systematic review and meta-analysis
Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage
Neutrophil–Platelet and Monocyte–Platelet Aggregates in COVID-19 Patients
Efficient oral vaccination by bioengineering virus-like particles with protozoan surface proteins
Intrathymic adeno-associated virus gene transfer rapidly restores thymic function and long-term persistence of gene-corrected T cells
Regulatory T cells in the treatment of disease
Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization
Reproducibility and Reuse of Adaptive Immune Receptor Repertoire Data
Molecular signatures of neural connectivity in the olfactory cortex
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases
Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients
Selective IL-2 Responsiveness of Regulatory T Cells Through Multiple Intrinsic Mechanisms Supports the Use of Low-Dose IL-2 Therapy in Type 1 Diabetes
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25
Erratum: Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25
TCR sequences and tissue distribution discriminate the subsets of naïve and activated/memory Treg cells in mice
Interleukin-5–producing group 2 innate lymphoid cells control eosinophilia induced by interleukin-2 therapy
Enveloped Virus-Like Particle Expression of Human Cytomegalovirus Glycoprotein B Antigen Induces Antibodies with Potent and Broad Neutralizing Activity